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ABSTRACT
Background and the purpose of the Study: Extract of Boswellia Serrata species has been used in 
the Indian traditional medicine in the treatment of various inflammatory diseases. The present 
study was designed to evaluate anti-inflammatory effects of Frankincense in the treatment of 
gingivitis, which is a periodontal tissue inflammatory disease.
Methods: This double blind randomized placebo controlled trial was carried out among high 
school female students with moderate plaque-induced gingivitis. Based on either administration 
of 0.1 gram of Frankincense extract or 0.2 gram of its powder or placebo and whether the 
patients undergone scaling and root planning (SRP) or not, they were randomly assigned to 6 
groups. The primary efficacy outcome was changes in Gingival Index (Loe & Sillness) and the 
secondary outcomes were alteration in plaque index (Sillness & Loe), bleeding index (Cowell) 
and probing pocket depth (WHO probe). All indices were measured in the 0, 7th and 14th days 
of the study.
Results: Seventy five patients ranged of 15-18 years old were enrolled. At the end of the study, 
the indices in all groups showed significant decreases in comparison to the first day (p< 0.05), 
except for the bleeding index in the group without SRP and drug therapy (p=0.111). More 
precise analysis of data revealed that SRP in association with Frankincense application (either 
extract or powder) can lead to remarkable decrease in inflammatory indices in comparison to 
the groups without SRP and drug therapy (p<0.001). In addition, no significant difference was 
observed between powder or extract therapy (p >0.05) and between patients received either SRP 
or treatment alone (p=0.169).
Conclusion: Frankincense, a safe and low-cost herbal medicine, may be feasibly applied to 
improve inflammation based disease of gingival as an adjunct to the conventional mechanical 
therapy.
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INTRODUCTION
Gingivitis in its most common form, plaque-induced 
gingivitis, results from interactions of immune 
system and existing biofilm. Inflammation as the 
major  pathological manifestation of periodontal 
diseases is a part of the immune system response to 
overcome aggregated microorganisms in the plaque. 
The more severe the response and aggregation of 
inflammatory  cells  and  mediators,  the  more  the 
destruction of periodontal tissues. Basically, plaque 
removal and inflammation reduction are achieved by 
means of scaling and root planning (SRP) and anti-
inflammatory  medications,  respectively.  As  daily 
use of non-opioid analgesics such as non-steroidal 
anti-inflammatory  drugs  (NSAIDs)  and  selective 
cyclooxygenase inhibitors (e.g., Celecoxib) can 
result in complications such as gastrointestinal 
bleeding, hypertension, congestive heart and renal 
failures (1), special attention has been recently paid 
to selective lipooxygenase inhibitors. Frankincense, 
a  resin-like  extract  of  Bowsellia  species  from 
Burseracea family, possessing Boswellic acid (B.A) 
288is a pentacyclic terpeniod that has been used in the 
Indian Ayurvedic traditional medicine (ayur: life, 
veda: knowledge) for many years (2). It has been 
demonstrated  that  Acetyl  Keto  Boswellic  Acid 
(AKBA), as the most active component of boswellia 
extract, is a selective non-oxidative inhibitor of 5-
lipooxygenase pathway (3). This pathway is the key 
pathway of leukotriens production from arachidonic 
acid in the cellular inflammatory cascade. Besides, 
the role of boswellic acid and Frankincense extract 
has  been  assessed  in  inflammatory  diseases  (4). 
Other herbal medication such as German Chamomile 
mouth wash has been reported to reduce dental 
plaque and gingival inflammation (5). Absence of 
acute or chronic adverse effects of Frankincense 
in animals and humans has been guaranteed 
the  low  risk  of  daily  use  of  this  medication  (6). 
Taking  into  consideration  the  anti-inflammatory 
and  antibacterial  effects,  low-cost,  availability  of 
Frankincense and also relatively high frequency 
of gingivitis, this study was designed to assess the 
effect of Frankincense powder or extract in the 
treatment of gingivitis.
MATERIAL AND METHODS 
Study design and eligibility criteria
A  randomized,  double-blinded  (patient,  clinician, 
biostatician), placebo controlled; parallel assigned 
trial was conducted to determine the safety and 
efficacy of Frankincense derivatives for treatment of 
plaque induced gingivitis among female high school 
students. The students with systemic diseases such as 
diabetes mellitus, hypertension and gastrointestinal 
diseases and also those who had used antibiotics 
or any other periodontal affecting drugs during 
the previous month were excluded from the study. 
Besides students with severe malocclusion teeth 
crowding, prior periodontal surgery and scaling 
and root planning (SRP) during the last 6 months 
along with profound Ramjford teeth decay or filling 
were excluded from the study. The patient parents or 
guardians were asked to write informed consent. 
Group assignment & Medicaments preparation 
Six  groups  were  designed  as  follows:  group  1 
(only extract), group 2 (only powder), group 3 (no 
medicament, no SRP), group 4 (extract and SRP), 
group 5 (powder and SRP) and group 6 (only SRP). 
Extracts and powders were prepared from an Indian 
species, Boswellia Serrata. 
The placebo (sugar free gum which does not contain 
any medicament) with the same shape and colour 
and amount prepared by the same pharmacist who 
was also responsible for preparation of drugs for 
entire study. Extract and powder were prepared from 
an Indian species, Boswellia Serrata. samples were 
purchased from registered local herbal medicines 
market. The physical and botanical characteristics of 
Frankincense were identified and authenticated by 
an expert specialist in herbal section of  Department 
of  Pharmacology,  Faculty  of  Medicine,  Babol 
University of Medical Science, Babol, Iran and a 
voucher specimen (No: CS_00235) was deposited. 
Extraction  was  carried  out  on  fine  powder  by 
maceration in 95% ethanol for 48hrs.  After filtration, 
the  filtrate  was  concentrated  in  rotary  evaporator 
apparatus and then it was added into gum base to 
make 0.1% w/w preparation. Powder was prepared 
by the same process as for the extract and was 
available as gum containing 0.2% w/w. Gum base 
was  obtained  from  commercially  available  sugar-
free samples from the market.
Study protocol
After  informed  consent  and  final  enrolment,  the 
participants were subjected to receive either 0.1 g of 
the extract or 0.2 g powder (in the form of chewing 
gums) or placebo (pure chewing gums) with or 
without scaling. SRP was performed at the beginning 
of the study and participants were instructed to chew 
three times per day, a gum each time, for 14 days. 
All groups were also provided with Oral Hygiene 
instruction  (OHI)  and  safety  issues  to  report  any 
allergy and sensitivity, itching and burning, severe 
bleeding, ulcer formation or any adverse effects 
possibly caused by the prescribed medicaments. 
Primary and secondary end points
All indices including Gingival Index (GI), Plaque 
Index (PI), Bleeding Index (BI) and Pocket Probe 
Depth (PPD) were recorded at the beginning of the 
study. The primary efficacy outcome was changes in 
GI (7) and the secondary outcomes were alteration 
in PI (8), BI (9) and PPD (WHO probe) and other 
side effects. All indices were measured in the 0, 7th 
and 14th days of the study by the same clinician 
with the above mentioned indices in a standard 
light. 
Statistical analyses
Alteration of each index within each group and 
comparison of same index between groups were 
assessed by means of repeated measure Analysis 
of  Variance  (ANOVA)  and  One-way  ANOVA, 
respectively.  In  addition  mean  difference  of  each 
index (Mean Diff.) during the study and overall 
difference computing for all 4 indices (Total diff.) 
was designated to reveal the group in which higher 
level of differences (Improvement in inflammatory 
indices) was achieved. Finally a pooled group (i.e., 
A [(only drug therapy (combination of groups 1 and 
2)], B [without SRP and drug therapy (group 3)], C 
[SRP and drug therapy (combination of groups 4 
and 5)] and D [only SRP: (group 6)] designs were 
taken into account to investigate putative effect of 
medicament. Further, a two-tailed α at p value <0.05 
was considered statistically significant. This study 
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reviewed and approved by the ethical committee 
of Babol University of Medical Sciences and all 
investigations were undertaken according to Helsinki 
treaty.
RESULTS
Study population
Patient  recruitment  accomplished  among  female 
high school students at Babol discrete, Mazandaran 
province,  Iran  during  2004-2006.  Among  465 
students which were assessed for enrollement, 145 
had plaque induced gingivitis of which 90 students 
were  included  in  the  study.  The  most  common 
reason for ineligibility fell into the category of 
corticosteroids medication followed by systemic 
disease  and  option  not  to  participate. Among  90 
recruited students, a total of 74 (82%) patients which 
were  randomly  assigned  to  group  1(only  extract, 
n=15), group 2 (only powder, n=14), group 3 (no 
medicament and no SRP, n=15), group 4 (extract and 
SRP, n=10), group 5 (powder and SRP, n=10) and 
group 6 (only SRP, n=10) completed the study and 
included in the final analysis. 
Baseline characteristics
Characteristics of baseline indices of the patients 
are listed in table 1 in the day of 0 column for each 
variable and group. Regarding the comparison 
of baseline characteristics between groups of the 
study, a significant difference was observed for all 4 
indices, therefore a day by day comparison of groups 
was overlooked and Mean and Total Diff. were used 
in calculation.  
Primary and secondary end points: Within group 
analysis
Tracing  fluctuation  of  indices  within  each  group 
and inter group comparison clarified that at the end 
of the study, there were improvement in all indices 
in comparison to the day 0 of the study (p<0.001), 
except for bleeding index in group 6 (no SRP and 
medicaments, p=0.111) ( Table 1). 
Primary and secondary end points: Between group 
analysis
Differences of changes of indices in the 6 groups were 
statistically significant (p<0.001), when inter groups 
were compared. For comparison of effects of extract 
and powder, comparisons were made between groups 
1, 2 and 4, 5. There was no differences between type 
of medicaments [Post Hoc Bonferroni (group 4 vs.5, 
p=0.92, (groups 1 vs. 2, p=1)]. Also, it was clear that 
drugs (extract or powder) had a positive effect in the 
improvement of indices [Post Hoc Bonferroni (group 
1 vs. 3, p=0.008) (group 2 vs. 3, p=0.048), (group 3 
vs. 4, p<0.001), (group 3 vs. 5, p=0.002)]. It was 
figured out that SRP has no significant difference in 
comparison to groups without SRP, with or without 
medicaments administration [Post Hoc Bonferroni 
(group 3vs. 6, p=1), (group 2 vs. 5 p=1), (group 1 vs. 
4, p=0.064)]. A comparison between medicaments 
effects and SRP, showed that there was no significant 
difference in overall improvement of indices [Post 
Hoc Bonferroni (group 1 vs.6, p=0.619), (group 2 vs. 
6, p=1)] (Table 1). When Total Diff. was considered, 
groups showed statistically different effects in 
overall  indices  improvement  [F  (5,  68)  =9.32, 
p<0.001] while group 4 was superior [3.63(±1.15)] 
followed by group 5[2.85(±1.13)], 1[2.50(±0.96)], 
2[2.35(±0.97)],  6[1.75(±0.76)]  and  3[1.32(42)] 
(Table 1). Effects of size calculated for GI, PPD and 
PI were 0.98.
Primary and secondary end points: Pooled group 
analysis
Significant inter group differences were observed 
after analysis of pooled data from combined 
groups considering all indices [F (3, 51.68) =16.01, 
p<0.001].  Collectively,  group  C  showed  better 
outcomes when calculating the overall improvement 
in all 4 indices [3.24(±1.18)], followed by group 
A,  D  and  B  (Table  2).To  assess  the  effect  of 
medicaments or SRP on periodontium health status 
alone or together, further analyses were carried out. 
Medicaments with or without SRP were effective 
[Post Hoc Dunnett T3 (group A vs. B, p <0.001), 
(group C vs. D, p=0.002)], although SRP itself, had 
no remarkable effect [Post Hoc Dunnett T3 (group 
B vs. D, p=0.516), (group A vs. C, p=0.096). Sole 
treatment with either SRP or medicament had the 
same impact [Post Hoc Dunnett T3 (group A vs. 
D), p=0.169], meanwhile combination of SRP and 
medicament possessed a higher potency to promote 
periodontal health and to lessen inflammation [Post 
Hoc Dunnett T3 (group B vs. C, p<0.001)]. Sum 
of  all  indices  was  calculated  at  the  days  of  0,7 
and 14. Changing pattern of all pooled indices of 
comparisons between quadric pooled groups is 
displayed in figure 1.
DISCUSSION
In  this  study,  anti-inflammatory  effects  of  the 
extract and powder of Frankincense in the treatment 
of  plaque-induced  gingivitis  was  investigated. 
Improvement  of  inflammation  of  periodontium 
by the use of extract or powder of Frankincense 
was remarkable. These findings are in accordance 
with  results  of  previous  investigations  upon  anti-
inflammatory properties of Frankincense (4).
Relative superiority of extract to powder which 
was  not  significant  may  be  explained  by  higher 
concentration of active components in the resin 
extract of Frankincense  when compared to the 
powder preparation. In both assessment of 6 and 
combined  4  groups,  the  most  improvement  was 
found  in  groups  with  medicament.  Nevertheless, 
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Index Group€ Day of 0
Mean (SD)
Day of 7
Mean (SD)
Day of 14
Mean (SD)
Significance† Mean Diff.
Mean (SD)*
Gingival Index
1 1.51(0.23) 1.02(0.23) 0.78(1.23)
F(1.13,18.38)=58.22, 
p<0.001
0.73(0.32)
2 1.53(0.30) 1.13(0.30) 0.88(0.27)
F(2,26,)=75.66
p<0.001
0.64(0.20)
3 1.40(0.19) 1.21(0.21) 1.1(0.19)
F(2,28)=65.95
p<0.001
0.30(0.09)
4 1.47(0.43) 0.87(0.28) 0.60(0.29)
F(1.14,10.32)=27.34
p<0.001
0.87(0.46)
5 1.16(0.27) 0.72(0.18) 0.48(0.15)
F(1.16,10.49)=83.15
p<0.001
0.67(0.21)
6 1.35(0.16) 1.12(0.14) 0.93(0.16)
F(2,18)=50.98
p<0.001
0.41(0.14)
Significance†† p=0.025
F(5,29.05)=7.37
p<0.001
Bleeding Index
1 1.53(0.41) 0.77(0.33) 0.52(0.33)
F(1.13,18.38)=75.78
p<0.001
0.82(0.33)
2 1.36(0.50) 0.90(0.43) 0.65(0.42)
F(2,26)=54.01
p<0.001
0.70(0.30)
3   1.14(0.38) 0.87(0.41) 0.73(0.41)
F(2,28)=54.40
p<0.001
0.40(0.16)
4 1.10(0.56) 0.42(0.24) 0.19(0.21)
F(2.27,11.47)=38.18
p<0.001
0.43(0.13)
5 0.70(0.32) 0.17(0.10) 0.06(0.04)
F(1.15,10.37)=38.18
p<0.001
0.30(0.09)
6  0.76(0.32) 0.58(0.37) 0.45(0.37)
F(1.09,9.81)=3.03
p<0.001
0.48(0.15)
Significance†† p=0.048
F(5,68)=1.64
p<0.001
Plaque Index
1 1.14(0.41) 1.06(0.45) 0.93(0.34)
F(2,28)=27.99
p<0.001
0.47(0.29)
2 1.46(0.54) 1.05(0.42) 1.01(0.42)
F(1.12,14.57)=11.01
p<0.001
0.44(0.43)
3 1.23(0.42) 0.95(0.38) 0.91(0.93)
F(2,28)=13.90
p<0.001
0.32(0.29)
4 1.84(0.59) 0.56(0.27) 0.42(0.21)
F(1.16,10.47)=43.61
p<0.001
1.42(0.62)
5 1.70(0.50) 0.64(0.28) 43(0.26)
F(1.12,10.10)=40.51
p<0.001
0.74(0.46)
6  1.36(0.49) 0.65(0.35) 0.62(0.35)
F(,)=
p<0.001
0.70(0.59)
Significance†† p=0.001
F(5.42,136)=10.70
p<0.001
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Index Group€ Day of 0
Mean (SD)
Day of 7
Mean (SD)
Day of 14
Mean (SD)
Significance† Mean Diff.
Mean (SD)*
Pocket Probe Index
1 1.71(0.50) 1.48(0.41) 1.21(0.27)
F(2,28)=23.41
p<0.001
2.53(0.96)
2 1.89(0.46) 1.62(0.34) 1.33(0.28)
F(2,26)=30.36
p<0.001
2.35(0.97)
3 1.76(0.42) 1.63(0.35) 1.74(0.31)
F(1.41,19.87)=13.64
p<0.001
1.32(0.42)
4 1.61(0.44) 1.30(0.30) 1.18(0.30)
F(1.07,9.68)=34.83
p<0.001
3.23(1.15)
5 1.32(0.24) 1.12(0.15) 1.06(0.13)
F(1.14,10.02)=22.80
P=0.001
1.75(0.76)
6 1.53(0.37) 1.34(0.17) 1.24(0.35)
F(1.13,10.23)=13.81
P=0.003
2.34(1.14)
Significance†† p=0.041
F(5,68)=9.32
p<0.001
€ Group definition: group 1(only extract), group 2 (only powder), group 3 (no medicament, no SRP), group 4( extract and SRP), group 
5 (powder with SRP) and group 6( only SRP)†Within group analysis total change-trend by repeated measurement ANOVA test (Time 
effect), †† between groups’ comparison of total change-trend by One-way ANOVA test.* Mean Diff. calculated for average days of 0-14 
changes. Day by day comparison was not allowed as groups differed significantly at the day of 0 (p<0.05), SD: standard deviation
Table 1. (Continue)
Group€ Gingival Index
Mean Diff.(SD)
Bleeding Index
Mean Diff.(SD)
Plaque Index
Mean Diff.(SD)
Pocket Probe Depth
Mean Diff.(SD)
Total Diff.†
(SD)
A 0.69(0.27) 0.76(0.32) 0.45(0.36) 0.53(0.32) 2.44(0.95)
B 0.30(0.09) 0.40(0.16) 0.32(0.29) 0.28(0.25) 1.32(0.42)
C 0.77(0.36) 0.78(0.39) 1.34(0.61) 0.34(0.20) 3.24(0.118)
D 0.41(0.14) 0.30(0.48) 0.74(0.46) 0.29(0.23) 1.75(0.76)
Significance†† F(3, 46)=14.68
p<0.001
F(2, 70)=7.95
p<0.001
F(3, 44.59)=20.01
p<0.001
F(2, 58.53)=4.41
p=0.007
F(3, 51.68)
p<0.001
€  Group definition: A [only drug therapy (combination of groups 1 and 2)], B [without SRP and drug therapy (group 3)], C [SRP and 
drug therapy (combination of groups 4 and 5) and D [ only SRP: (group 6)] †Total Diff: Average differences compared for all 4 indices, 
††   between groups’ comparison of change-trend by One-way ANOVA for mean differences calculated for day0-14 changes, SD: standard 
deviation.
Table 2. Changing Trends of Indices in Pooled Groups during the Study.
was  hampered  in  sole  SRP  groups,  although, 
this  difference  was  not  statistically  significant  (p 
value  <0.05).  In  addition,  in  groups  which  were 
subjected to medicament therapy or SRP, significant 
difference was observed in comparison to groups 
without  either  medicament  or  SRP.  Also,  other 
than the bleeding index in group which received 
neither medicament nor SRP (group 6), there were 
improvements of all indices in all groups, at the end 
of the study, compared to the first day of the study. It 
seems that excessive inflammatory reactions due to 
the mechanical SRP traumatic forces may proceed 
to obscure the remedial effect of pure chewing 
gums. It is probable that, by increasing the follow 
up period up to one month and more, useful effects 
of mechanical deletion of plaque may become 
more  evident.  It  should  be  mentioned  that  low 
sample sizes of the studied groups may under- or 
overestimated the reported outcomes. A 30 percent 
lost-to-follow up rate in some groups is better to 
be considered as another limitation and reporting 
bias  of  the  present  work.  Previously  Jing  et  al 
highlighted that Boswellia may exert its effects in a 
dose and time dependent manner (10). Besides, one 
should consider that change  in patterns may have 
gradual fashion continued 1-3 months after phase I 
therapy (11). Improvements in other indices (PI, GI, 
and PPD) in group 6 probably is related to effects of 
improved regional blood flow (12) and mechanical 
ablation  of  plaque  perceived  by  chewing  (13). 
Cochrane authentic review in 2008 has challenged 
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of AKBA to suppress inflammation in chronic setting 
may be due to overproduction of peroxidase during 
oxidative stresses in oxi-redox interactions. In the 
work described, chewing gum which contained 
neither powder nor extract of Frankincense was 
used as placebo in the control group. Considering 
previous reports on the local effect of the gum 
on gingivitis with probable augmentation of the 
microcirculation  (12),  concern  may  be  raised 
upon biased conclusion about independent anti 
inflammatory effect of Frankincense. 
CONCLUSION
Result of this investigation displayed anti 
inflammatory  properties  of  Frankincense extract 
on  chronic  plaque  induced  gingivitis. This  herbal 
medicament may be feasibly and safely applied 
to  improve  gingival  health.  This  naturaceutical 
exhibits satisfactory remedial properties, which is 
comparable and even superior to scaling and root 
planning  (SRP)  as  the  current  standard  of  dental 
plaque removal which are costly and discomfort 
during the procedure.
Figure 1. Changing trends of the whole periodontal indices compared between combined groups.
One way ANOVA analysis displayed p=0.089, p<001 and p<0.001 between groups differences at the beginning day and the days of 7 and 
14  respectively. * Day of 7 analysis revealed that group C has less inflammation in comparison to group A (p<0.001), group B (p<0.001) 
and Group D (p=0.04). ** At the day of 14, group C overall inflammatory measures were significantly lower than group A (p<0.001), 
group B (p<0.001) and Group D (p=0.008).
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